Logo image of AXIL

AXIL BRANDS INC (AXIL) Stock Fundamental Analysis

USA - NYSEARCA:AXIL - US76151R2067 - Common Stock

7 USD
0 (0%)
Last: 9/12/2025, 8:04:03 PM
7.5 USD
+0.5 (+7.14%)
After Hours: 9/12/2025, 8:04:03 PM
Fundamental Rating

5

AXIL gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 36 industry peers in the Personal Care Products industry. AXIL is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. AXIL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

AXIL had positive earnings in the past year.
AXIL had a positive operating cash flow in the past year.
In multiple years AXIL reported negative net income over the last 5 years.
In multiple years AXIL reported negative operating cash flow during the last 5 years.
AXIL Yearly Net Income VS EBIT VS OCF VS FCFAXIL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M 2M 3M

1.2 Ratios

AXIL has a Return On Assets of 19.15%. This is amongst the best in the industry. AXIL outperforms 97.22% of its industry peers.
AXIL's Return On Equity of 25.68% is amongst the best of the industry. AXIL outperforms 91.67% of its industry peers.
AXIL has a Return On Invested Capital of 10.72%. This is in the better half of the industry: AXIL outperforms 75.00% of its industry peers.
Industry RankSector Rank
ROA 19.15%
ROE 25.68%
ROIC 10.72%
ROA(3y)9.28%
ROA(5y)-2.18%
ROE(3y)-9.42%
ROE(5y)-29.73%
ROIC(3y)N/A
ROIC(5y)N/A
AXIL Yearly ROA, ROE, ROICAXIL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

The Profit Margin of AXIL (9.18%) is better than 80.56% of its industry peers.
The Operating Margin of AXIL (4.76%) is comparable to the rest of the industry.
AXIL has a better Gross Margin (71.40%) than 69.44% of its industry peers.
In the last couple of years the Gross Margin of AXIL has grown nicely.
Industry RankSector Rank
OM 4.76%
PM (TTM) 9.18%
GM 71.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.09%
GM growth 5Y10.63%
AXIL Yearly Profit, Operating, Gross MarginsAXIL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AXIL is still creating some value.
The number of shares outstanding for AXIL has been increased compared to 1 year ago.
Compared to 5 years ago, AXIL has more shares outstanding
Compared to 1 year ago, AXIL has an improved debt to assets ratio.
AXIL Yearly Shares OutstandingAXIL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
AXIL Yearly Total Debt VS Total AssetsAXIL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

An Altman-Z score of 11.64 indicates that AXIL is not in any danger for bankruptcy at the moment.
The Altman-Z score of AXIL (11.64) is better than 94.44% of its industry peers.
The Debt to FCF ratio of AXIL is 0.13, which is an excellent value as it means it would take AXIL, only 0.13 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.13, AXIL belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that AXIL is not too dependend on debt financing.
AXIL's Debt to Equity ratio of 0.01 is fine compared to the rest of the industry. AXIL outperforms 72.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.13
Altman-Z 11.64
ROIC/WACC1.23
WACC8.68%
AXIL Yearly LT Debt VS Equity VS FCFAXIL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M

2.3 Liquidity

AXIL has a Current Ratio of 3.78. This indicates that AXIL is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.78, AXIL belongs to the top of the industry, outperforming 80.56% of the companies in the same industry.
AXIL has a Quick Ratio of 2.66. This indicates that AXIL is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of AXIL (2.66) is better than 80.56% of its industry peers.
Industry RankSector Rank
Current Ratio 3.78
Quick Ratio 2.66
AXIL Yearly Current Assets VS Current LiabilitesAXIL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

3

3. Growth

3.1 Past

AXIL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 102.79%, which is quite impressive.
Looking at the last year, AXIL shows a decrease in Revenue. The Revenue has decreased by -3.17% in the last year.
AXIL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 94.30% yearly.
EPS 1Y (TTM)102.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.75%
Revenue 1Y (TTM)-3.17%
Revenue growth 3Y156.26%
Revenue growth 5Y94.3%
Sales Q2Q%7%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AXIL Yearly Revenue VS EstimatesAXIL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 25.00, AXIL is valued on the expensive side.
AXIL's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.30. AXIL is around the same levels.
Industry RankSector Rank
PE 25
Fwd PE N/A
AXIL Price Earnings VS Forward Price EarningsAXIL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

AXIL's Enterprise Value to EBITDA ratio is in line with the industry average.
AXIL's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 43.92
EV/EBITDA 29.39
AXIL Per share dataAXIL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for AXIL!.
Industry RankSector Rank
Dividend Yield N/A

AXIL BRANDS INC

NYSEARCA:AXIL (9/12/2025, 8:04:03 PM)

After market: 7.5 +0.5 (+7.14%)

7

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-20 2025-08-20
Earnings (Next)10-09 2025-10-09
Inst Owners12.44%
Inst Owner Change-8.52%
Ins Owners22.33%
Ins Owner Change0%
Market Cap46.62M
AnalystsN/A
Price TargetN/A
Short Float %0.22%
Short Ratio0.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 25
Fwd PE N/A
P/S 1.73
P/FCF 43.92
P/OCF 33.36
P/B 4.83
P/tB 6.52
EV/EBITDA 29.39
EPS(TTM)0.28
EY4%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.16
FCFY2.28%
OCF(TTM)0.21
OCFY3%
SpS4.06
BVpS1.45
TBVpS1.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 19.15%
ROE 25.68%
ROCE 12.24%
ROIC 10.72%
ROICexc 19.33%
ROICexgc 33.66%
OM 4.76%
PM (TTM) 9.18%
GM 71.4%
FCFM 3.93%
ROA(3y)9.28%
ROA(5y)-2.18%
ROE(3y)-9.42%
ROE(5y)-29.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.09%
GM growth 5Y10.63%
F-Score4
Asset Turnover2.09
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.13
Debt/EBITDA 0.1
Cap/Depr 240.07%
Cap/Sales 1.24%
Interest Coverage 267.69
Cash Conversion 98.08%
Profit Quality 42.81%
Current Ratio 3.78
Quick Ratio 2.66
Altman-Z 11.64
F-Score4
WACC8.68%
ROIC/WACC1.23
Cap/Depr(3y)63.97%
Cap/Depr(5y)86.71%
Cap/Sales(3y)0.29%
Cap/Sales(5y)0.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)102.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.75%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.17%
Revenue growth 3Y156.26%
Revenue growth 5Y94.3%
Sales Q2Q%7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-32.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-52.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-38.83%
OCF growth 3Y-61.79%
OCF growth 5YN/A